Summary of Purpose
The purpose of this study is to determine the safety and efficacy of lowering glucose (blood sugar), in addition to endovascular therapy, after acute ischemic stroke. The study will determine if lowering glucose (blood sugar) in addition to endovascular therapy will improve 90-day functional and neurological outcomes in comparison to standard glycemic care in patients with acute ischemic stroke. The study will...Read More →
The following dates are available for this trial. Trial information last updated on 3 February 2014.
|1 Jan 2013||31 Jan 2014||1 Dec 2016||1 Dec 2018||1 Jan 2014||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Allocation: Randomized
- Masking: Open Label
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
- Jen Gay, B.S.